비교리스트

 카트 문의
시장보고서
상품코드
1346940

모유 올리고당(HMO) 시장 점유율, 규모, 동향, 산업 분석 보고서 : 유형별, 용도별, 유통 경로별, 지역별, 부문별 예측(2023-2032년)

Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2´FL, 3´FL, 3´SL, 6´SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 새로운 연구에 따르면, 세계 모유 올리고당(HMO) 시장 규모는 2032년까지 17억 9,996만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트를 제공하고 향후 시장 성장에 대한 분석을 제공합니다.

모유 올리고당(HMOs)은 인간 모유에 자연적으로 존재하는 복합 탄수화물 또는 당으로, 인간 모유에만 존재하며 소의 모유를 포함한 다른 포유류 모유에는 상당한 양이 존재하지 않습니다.

HMO는 아기의 영양 공급원으로 작용하지만 아기가 직접 소화하지 않습니다. 대신 HMO는 프리바이오틱스로 작용하여 아기의 장내 유익한 박테리아의 먹이가 됩니다. 장내 세균총은 면역계 발달, 소화 및 전반적인 건강에 매우 중요하며, HMO는 유해한 병원균의 증식을 억제하면서 비피더스균과 같은 특정 유익한 박테리아의 증식을 선택적으로 촉진합니다.

모유 올리고당(HMOs)은 모유의 필수 성분으로 다양한 농도와 구성으로 제공되며, HMO의 고유한 특성으로 인해 사용 시 특정 규제 승인을 받아야 합니다. 미국에서 올리고당은 건강 보조 식품으로 분류되기보다는 식품에 포함될 수 있도록 허가되어 있으며, GRAS(Generally Recognized as Safe) 규제의 적용을 받습니다.

예를 들어, GRAS 승인을 받은 HMO 제품 라인은 듀폰이 개발한 CARE4U로, 유아용 조제분유와 유아용 식품에 활용되고 있습니다. 이 승인은 소비에 대한 안전성을 보장합니다. 또한, HMO에 대한 수요가 증가함에 따라 유럽위원회에서 HMO 사용에 대한 지지를 얻기 위해 새로운 식품 안전 평가가 이루어지고 있습니다.

모유 올리고당(HMOs)의 세계 채택이 증가하고 있습니다. 2022년 1월에 발표된 세계경제포럼의 기사에 따르면 2020년 일본의 출생아 수는 전년 대비 2.8% 감소하여 1899년 이후 최저치를 기록했습니다.

HMO에 대한 수요 증가는 생활습관 개선과 건강 및 웰빙에 대한 관심 증가에 기인하며, HMO는 장애를 해결하고 고위험 건강 상태를 완화하기 위해 기능성 음료 및 식품 보충제에 활용됩니다. 이러한 요인은 세계 HMO 산업의 성장에 크게 기여하고 있습니다. 그러나 HMO 제품과 관련된 높은 비용은 예측 기간 동안 시장 성장에 큰 도전이 될 것으로 예상됩니다.

COVID-19 팬데믹은 HMO 산업에 큰 영향을 미쳤습니다. 팬데믹 초기에는 소비자들이 집에서 소비하기 위해 공황 구매에 나서면서 HMO 수요가 급증했습니다. 그 결과, 면역력 강화 제품으로 여겨지는 HMO의 매출이 증가했습니다.

모유 올리고당(HMO) 시장 보고서 및 주요 내용

2022년에는 유아용 조제분유 설계에서 HMO에 대한 수요 증가로 인해 유아용 조제분유 분야가 가장 큰 시장 점유율을 차지했으며, HMO는 프리바이오틱스 효과, 감염 예방, 기억력 강화, 장 건강 유지, 뇌 발달 등의 유익한 특성을 제공합니다. 이러한 요인들은 유아용 조제분유에서 HMO에 대한 수요를 촉진합니다.

2022년에는 드럭스토어 또는 약국 부문이 모유 올리고당 시장에서 가장 높은 시장 점유율을 차지하며 지속적으로 성장할 것으로 예상됩니다. 이는 주로 통신 판매 업체 및 슈퍼 센터와의 경쟁이 치열 해짐에 따라이 부문이 고객 확보 및 유지에 중점을두고 있기 때문입니다.

아시아태평양에서는 유아의 영양과 전반적인 건강에서 HMO의 이점에 대한 인식이 높아짐에 따라 모유 올리고당(HMO) 시장이 크게 성장할 것으로 예상됩니다. 소비자들이 건강을 중시하고 유아를 위한 고품질 영양 옵션을 추구함에 따라 HMO에 대한 수요가 증가할 것으로 예상됩니다.

Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd, Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt.Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, Royal FrieslandCampina N.V. 등 전 세계에 진출해 있는 세계 모유 올리고당 산업을 선도하는 기업들입니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 모유 올리고당(HMO) 시장 인사이트

  • 모유 올리고당(HMO)- 업계 현황
  • 모유 올리고당(HMO) 시장 역학
    • 성장 촉진요인과 기회
      • 유아 인구 증가
      • 모유수유의 중요성에 대한 인식 확산
    • 성장 억제요인과 과제
      • 한정된 가용성
  • PESTEL 분석
  • 모유 올리고당(HMO) 시장 업계 동향
  • 밸류체인 분석
  • COVID-19 감염증의 영향 분석

제5장 세계의 모유 올리고당(HMO) 시장, 종류별

  • 주요 조사 결과
  • 서론
  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

제6장 세계의 모유 올리고당(HMO) 시장, 용도별

  • 주요 조사 결과
  • 서론
  • 유아용 조제분유
  • 기능성 식품·음료
  • 식이보충제

제7장 세계의 모유 올리고당(HMO) 시장, 유통 채널별

  • 주요 조사 결과
  • 서론
  • 하이퍼마켓과 슈퍼마켓
  • 드럭스토어 또는 약국
  • 온라인 판매 채널
  • 기타

제8장 세계의 모유 올리고당(HMO) 시장, 지역

  • 주요 조사 결과
  • 서론
    • 모유 올리고당(HMO) 시장 평가, 지역, 2019-2032
  • 모유 올리고당(HMO) 시장 - 북미
    • 북미 : 모유 올리고당(HMO) 시장, 유형별, 2019년에서 2032년
    • 북미 : 모유 올리고당(HMO) 시장, 유통 채널별, 2019-2032년
    • 북미 : 모유 올리고당(HMO) 시장, 용도별, 2019-2032년
    • 모유 올리고당(HMO) 시장 - 미국
    • 모유 올리고당(HMO) 시장 - 캐나다
  • 모유 올리고당(HMO) 시장 - 유럽
    • 유럽 : 모유 올리고당(HMO) 시장, 종류별, 2019-2032년
    • 유럽 : 모유 올리고당(HMO) 시장, 유통 채널별, 2019-2032년
    • 유럽 : 모유 올리고당(HMO) 시장, 용도별, 2019-2032년
    • 모유 올리고당(HMO) 시장 - 영국
    • 모유 올리고당(HMO) 시장 - 프랑스
    • 모유 올리고당(HMO) 시장 - 독일
    • 모유 올리고당(HMO) 시장 - 이탈리아
    • 모유 올리고당(HMO) 시장 - 스페인
    • 모유 올리고당(HMO) 시장 - 네델란드
    • 인 유올리고당(HMO) 시장 - 러시아
  • 모유 올리고당(HMO) 시장 - 아시아태평양
    • 아시아태평양 : 모유 올리고당(HMO) 시장, 종류별, 2019-2032년
    • 아시아태평양 : 모유 올리고당(HMO) 시장, 유통 채널별, 2019-2032년
    • 아시아태평양 : 모유 올리고당(HMO) 시장, 용도별, 2019-2032년
    • 모유 올리고당(HMO) 시장 - 중국
    • 모유 올리고당(HMO) 시장 - 인도
    • 모유 올리고당(HMO) 시장 - 말레이시아
    • 모유 올리고당(HMO) 시장 - 일본
    • 인 유올리고당(HMO) 시장 - 인도네시아
    • 모유 올리고당(HMO) 시장 - 한국
  • 모유 올리고당(HMO) 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 모유 올리고당(HMO) 시장, 종류별, 2019-2032년
    • 중동 및 아프리카 : 모유 올리고당(HMO) 시장, 유통 채널별, 2019-2032년
    • 중동 및 아프리카 : 모유 올리고당(HMO) 시장, 용도별, 2019-2032년
    • 모유 올리고당(HMO) 시장 - 사우디아라비아
    • 모유 올리고당(HMO) 시장 - 아랍에미리트
    • 모유 올리고당(HMO) 시장 - 이스라엘
    • 모유 올리고당(HMO) 시장 - 남아프리카공화국
  • 모유 올리고당(HMO) 시장 - 라틴아메리카
    • 라틴아메리카 : 모유 올리고당(HMO) 시장, 유형별, 2019년에서 2032년
    • 라틴아메리카 : 모유 올리고당(HMO) 시장, 유통 채널별, 2019-2032
    • 라틴아메리카 : 모유 올리고당(HMO) 시장, 용도별, 2019년에서 2032년
    • 모유 올리고당(HMO) 시장 - 멕시코
    • 모유 올리고당(HMO) 시장 - 브라질
    • 모유 올리고당(HMO) 시장 - 아르헨티나

제9장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Abbott Laboratories
  • BASF S.E
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • Royal FrieslandCampina N.V
  • ZuChem
ksm 23.10.24

The global human milk oligosaccharides (HMO) market size is expected to reach USD 1,799.96 million by 2032, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Milk Oligosaccharides (HMOs) are complex carbohydrates or sugars naturally found in human breast milk. HMOs are unique to human milk and are not present in significant amounts in other mammalian milk, including cow's milk.

HMOs serve as a source of infant nutrition, although the baby does not directly digest them. Instead, they act as prebiotics, which means they serve as food for beneficial bacteria in the infant's gut. The gut microbiota is crucial in immune system development, digestion, and overall health. HMOs selectively promote the growth of specific beneficial bacteria, such as Bifidobacteria, while inhibiting the growth of harmful pathogens.

Human Milk Oligosaccharides (HMOs) are essential constituents of human breast milk and are available in various concentrations and compositions. The unique nature of HMOs requires specific regulatory approvals for their use. In the United States, oligosaccharides are authorized to be incorporated into food products rather than categorized as dietary supplements and are subject to the Generally Recognized as Safe (GRAS) regulations.

For instance, the GRAS-approved HMO product line is CARE4U, developed by DuPont, which is utilized in infant formula and toddler foods. This approval ensures its safety for consumption. Furthermore, the growing demand for HMOs has led to a novel food safety assessment to seek support from the European Commission for their usage.

The global adoption of Human Milk Oligosaccharides (HMOs) has increased. According to a World Economic Forum article published in January 2022, the number of births in Japan decreased by 2.8% in 2020 compared to the previous year, reaching its lowest point since 1899.

The increasing demand for HMOs can be attributed to lifestyle improvements and a growing focus on health and wellness. HMOs are utilized in functional food and beverage products and food supplements to address disorders and mitigate high-risk health conditions. This factor has significantly contributed to the growth of the global HMO industry. However, the high costs associated with HMO products are expected to pose a major challenge to market growth during the forecast period.

The COVID-19 pandemic has had a significant impact on the HMO industry. During the initial phase of the pandemic, there was a surge in demand for HMOs as consumers engaged in panic buying for at-home consumption. It resulted in increased sales of HMOs, considered immune-boosting products.

Human Milk Oligosaccharides (HMO) Market Report Highlights

In 2022, the infant formula segment accounted for the largest market share due to the increasing demand for HMOs in infant formula design. HMOs offer beneficial properties like prebiotic effects, infection prevention, memory enhancement, gut health maintenance, and brain development. These factors drive the demand for HMOs in infant formulas.

In 2022, the drug store or pharmacy segment held the highest market share in the Human Milk Oligosaccharides market and is projected to continue growing. It is primarily due to the segment's focus on attracting and retaining customers amidst rising competition from mail-order retailers and supercenters.

The Asia Pacific region expected to witness significant growth in the Human Milk Oligosaccharides (HMO) market due to growing awareness of the benefits of HMOs in infant nutrition and overall health in the region. As consumers become more health-conscious and seek high-quality nutrition options for their infants, the demand for HMOs is expected to rise.

The global Human Milk Oligosaccharides industry players with a global presence including Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:

Human Milk Oligosaccharides (HMO), Type Outlook (Revenue - USD Million, 2019 - 2032)

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

Human Milk Oligosaccharides (HMO), Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

Human Milk Oligosaccharides (HMO), Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Online Sales Channel
  • Others

Fogless Mirror, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 4.1. Human Milk Oligosaccharides (HMO) - Industry Snapshot
  • 4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the infant population
      • 4.2.1.2. Growing awareness of the importance of breastfeeding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Milk Oligosaccharides (HMO) Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. 2'FL
    • 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2019 - 2032 (USD Million)
  • 5.4. 3'FL
    • 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2019 - 2032 (USD Million)
  • 5.5. 3'SL
    • 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2019 - 2032 (USD Million)
  • 5.6. 6'SL
    • 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2019 - 2032 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Infant Formula
    • 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2019 - 2032 (USD Million)
  • 6.4. Functional Food & Beverage
    • 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2019 - 2032 (USD Million)
  • 6.5. Food Supplements
    • 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2019 - 2032 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • 7.3. Hypermarkets & Supermarkets
    • 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2019 - 2032 (USD Million)
  • 7.4. Drug Store or Pharmacy
    • 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Drug Store or Pharmacy, by Region, 2019 - 2032 (USD Million)
  • 7.5. Online Sales Channel
    • 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Online Sales Channel, by Region, 2019 - 2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, by Others, by Region, 2019 - 2032 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Human Milk Oligosaccharides (HMO) Market - North America
    • 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Human Milk Oligosaccharides (HMO) Market - U.S.
      • 8.3.4.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Human Milk Oligosaccharides (HMO) Market - Canada
      • 8.3.5.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Human Milk Oligosaccharides (HMO) Market - Europe
    • 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
      • 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
      • 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
      • 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
      • 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
      • 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
      • 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
      • 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
      • 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
      • 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
      • 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
      • 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
      • 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
      • 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
      • 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
      • 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
      • 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
    • 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
      • 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
      • 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
      • 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BASF S.E
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biosynth Carbosynth
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chr. Hansen Holding A/S
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dextra Laboratories Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dupont Nutrition & Biosciences
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Elicityl S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Glycom A/S
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Glycosyn
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Inbiose NV
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medolac Laboratories
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Neolacta Lifesciences Pvt. Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Nestle Health Science
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Royal DSM
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Royal FrieslandCampina N.V
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. ZuChem
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제